Analyses estimating program costs collected on a subsample of facilities are subject to statistical uncertainty, often quantified via standard errors and/or 95% confidence intervals. This recent publication elaborates methods to reduce statistical uncertainty.
Local engagement and empowerment have been essential for the DOVE study to develop cost of illness estimates and apply them to policymaking and program planning in Uganda. Here are some ideas and tools you can use...
Three modules were published from TVEE's vaccine economics curriculum, available to the public for free, on the JHSPH OpenCourseWare (OCW). Anybody can now download lecture slides, syllabi and exercises from this curriculum. Read more here
Catalyst funding is available to support scientists in bacterial vaccinology to explore new approaches and strategies to advance their vaccines in partnership with LMICs and across the academia/industry divide. Read more here.
Recent study estimate cost drivers and unit costs of Immunization and other essential services package in Bangladesh. Supplemented with epidemiological and demographical data, this information could be used to help with policy and decision making. Read more here
Fifth Advanced Course on Health Financing for Universal Coverage for LMIC, to be held from 18 to 22 June 2018 in Tunis, Tunisia. Apply by Thursday 1 March 2018 at midnight (Geneva, Switzerland time). Read more here
A new analysis of health and household economic impact of 10 vaccine antigens across income quintiles for 41 low- and middle-income countries indicates predominant benefit in lowest quintiles, improving health equity. Read more here.
A new publication explains main challenges that countries and donors face in achieving smooth transitions, points to the key strategies and tools that should be used and outlines a recommended agenda for priority research in this area. Read more here.
Benin’s commitment to immunization continues to grow, though sustainability of financing remains a concern. Comparisons with neighboring countries reveal potential lessons for Benin, around efficiency and sustainability. Read more here.
Help ministries of health and UNICEF partners engage effectively with the private providers/sectors to expand immunization coverage and reduce inequities. Proposal deadline Feb 19, (11am Amman time). Read more here.
The workshops series in Jaipur, Karachi, and Kampala focuses on capacity building in applied vaccine economics and financing. Read more here
This short report revealed community members' demographics, location and area of work, the projects they work on, the identified public resource, and current needs in methodological guide.
In the October 2017 Newsletter Issue, Dr. Brenzel thanks and welcomes the members of the Immunization Economics Community of Practice. Read her welcome letter here.
Dr Orin Levine: "Virtually every child in the world can access a Coca-Cola, yet globally, one in every seven children is still excluded from vaccines. In Africa, one in five go unvaccinated." Read more here
TVEE launched the first workshops of the series in Johannesburg, South Africa and Kampala, Uganda. The workshop series focuses on capacity building in applied vaccine economics, cost-effectiveness and finance. Read more here.
Using a standardised micro-costing tool, a new study presents the cost drivers of HPV vaccine delivery in low income countries and identifies optimal strategies to reduce costs without adversely impacting coverage. Read more here.
Your participation in this survey is crucial in helping us develop the evidence and resources to further the field of Immunization Economics. This survey should take around 20 minutes to complete. Thank you very much for your support. Take the survey here
National governments require economic data on burden of influenza disease, vaccine cost effectiveness , and projected implementation costs. The WHO has developed a value chain of economic analysis tools to cover this need. Read more here
There are few published Budget Impact Analyses (BIAs) compared with cost-effectiveness analyses (CEAs). This study proposes a framework to facilitate the uptake of budget impact of vaccines through CEA information in LMICs. Read more here.
A two-day Methods and Case Studies workshop in Boston seek to develop reference case guidelines for benefit-cost analysis in global health and development. Discussants include Larry Summers, Sue Goldie, and Dean Jamison. Read more here
Health Policy & Planning podcast discusses the importance in understanding detailed cost structure, its relationship with efficiency, and implications for health policy and future planning in immunization programs. Listen to podcast here.
Research helps stakeholders in Bangladesh and other countries make more informed decisions about the true economic burden of childhood diseases and better evaluate investments in vaccines. Read more here
Research teams & policymakers from Indonesia, Tanzania & Vietnam met in Hanoi to discuss costing study designs & cross cutting methods issues for the ICAN project - working towards sustainable immunization financing. Read more here
The Reference Case provides a guide to ensuring that the process of cost estimation is transparent and clear, enhancing the interpretation and use of quality cost data for decision making. See more here.
Health Policy and Planning blogpost examines how detailed understanding of the cost structure of immunization programs can inform policy. Read more here.
Focused on capacity building in applied vaccine economics, cost-effectiveness and finance, TVEE targets audience who are current decision-makers in EPI programs, NiTAGs and partners in GAVI eligible countries. Watch video here
The Value of Vaccination Research Network (VoVRN) is pleased to announce the initiation of a grant-making cycle to fund research on the broader social and economic impacts of vaccination (BSEIV) due Aug 4 2017. See instructions here.
Gavi committed to monitoring externalities of it activities in countries, and on manufacturers and partners. To do so, we are asking the public to help identify externalities of market shaping and how to monitor them. See more here
Submit new information [here]